REQUEST A DEMO
Total
USD $0.00
Search more companies

Endomed Janusz Romanowski sp. j. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Endomed Janusz Romanowski sp. j. Profile Updated: January 03, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Endomed Janusz Romanowski sp. j. is a company based in Poland, with its head office in Radom. It operates in the Ambulatory Health Care Services industry. It was incorporated on January 11, 2012. There was a net sales revenue increase of 28.25% reported in Endomed Janusz Romanowski sp. j.’s latest financial highlights for 2025. Over the same period, its total assets grew by 48.36%. The net profit margin of Endomed Janusz Romanowski sp. j. increased by 7.55% in 2025.

Headquarters
Ul. Jana Kilinskiego 6
Radom; Mazowieckie; Postal Code: 26-610

Contact Details: Purchase the Endomed Janusz Romanowski sp. j. report to view the information.

Website: http://www.endomed.radom.pl

Basic Information
Financial Auditors:
Purchase the Endomed Janusz Romanowski sp. j. report to view the information.
Incorporation Date:
January 11, 2012
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Endomed Janusz Romanowski sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
28.25%
Total Operating Revenue
29.61%
Operating Profit
182.21%
EBITDA
136.27%
Net Profit/Loss for the Period
182.17%
Total Assets
48.36%
Total Equity
52.26%
Operating Profit Margin
7.55%
Net Profit Margin
7.55%
Return on Equity (ROE)
25.29%
Quick Ratio
0.68%
Cash Ratio
0.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?